123 related articles for article (PubMed ID: 29599318)
1. Lentiviral Vector-mediated Gene Transfer in Human Bladder Cancer Cell Lines.
Matsunaga W; Ichikawa M; Nakamura A; Ishikawa T; Gotoh A
Anticancer Res; 2018 Apr; 38(4):2015-2020. PubMed ID: 29599318
[TBL] [Abstract][Full Text] [Related]
2. Targeted p53 activation by saRNA suppresses human bladder cancer cells growth and metastasis.
Wang C; Ge Q; Zhang Q; Chen Z; Hu J; Li F; Ye Z
J Exp Clin Cancer Res; 2016 Mar; 35():53. PubMed ID: 27012825
[TBL] [Abstract][Full Text] [Related]
3. Adenovirus-mediated delivery of p16 to p16-deficient human bladder cancer cells confers chemoresistance to cisplatin and paclitaxel.
Grim J; D'Amico A; Frizelle S; Zhou J; Kratzke RA; Curiel DT
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2415-23. PubMed ID: 9815642
[TBL] [Abstract][Full Text] [Related]
4. Expression of cell-cycle mediators in ovarian cancer cells after transfection with p16(INK4a), p21(WAF1/Cip-1), and p53.
Ramirez PT; Gershenson DM; Tortolero-Luna G; Ramondetta LM; Fightmaster D; Wharton JT; Wolf JK
Gynecol Oncol; 2001 Dec; 83(3):543-8. PubMed ID: 11733969
[TBL] [Abstract][Full Text] [Related]
5. [Effects of adenovirus-mediated p16 and p53 genes transfer on apoptosis and cell cycle of lung carcinoma cells].
Bai X; Che F; Li J; Ma Y; Zhou Y; Zhai J; Meng L
Zhonghua Bing Li Xue Za Zhi; 2000 Oct; 29(5):354-8. PubMed ID: 11866935
[TBL] [Abstract][Full Text] [Related]
6. [Multiple inhibitory mechanisms of wild-type p16 gene transfer into human bladder cells by retroviral vector].
Wu Y; Ma T; Wu H; Zhang W; Wu C
Zhonghua Wai Ke Za Zhi; 1999 Aug; 37(8):456-8. PubMed ID: 11829887
[TBL] [Abstract][Full Text] [Related]
7. Adenovirus-mediated transfer of p53 and p16 inhibiting proliferating activity of human bladder cancer cell EJ in vitro and in vivo.
Zhu Z; Xing S; Lin C; Zeng F; Lu G; Fu M; Zhang X; Liang X; Wu M
J Huazhong Univ Sci Technolog Med Sci; 2002; 22(4):324-6. PubMed ID: 12674770
[TBL] [Abstract][Full Text] [Related]
8. Bicistronic transfer of CDKN2A and p53 culminates in collaborative killing of human lung cancer cells in vitro and in vivo.
Xande JG; Dias AP; Tamura RE; Cruz MC; Brito B; Ferreira RA; Strauss BE; Costanzi-Strauss E
Gene Ther; 2020 Feb; 27(1-2):51-61. PubMed ID: 31439890
[TBL] [Abstract][Full Text] [Related]
9. Effects of exogenous wild-type P16 gene transfection on the expression of cell cycle-related proteins in bladder cancer cell line.
Li L; Yang T; Lian X
Cancer Invest; 2005; 23(4):309-15. PubMed ID: 16100943
[TBL] [Abstract][Full Text] [Related]
10. Additional gene therapy with rAAV-wt-p53 enhanced the efficacy of cisplatin in human bladder cancer cells.
Ruifa H; Liwei L; Binxin L; Ximing L
Urol Int; 2006; 77(4):355-61. PubMed ID: 17135787
[TBL] [Abstract][Full Text] [Related]
11. BTG2 is a tumor suppressor gene upregulated by p53 and PTEN in human bladder carcinoma cells.
Tsui KH; Chiang KC; Lin YH; Chang KS; Feng TH; Juang HH
Cancer Med; 2018 Jan; 7(1):184-195. PubMed ID: 29239139
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of orthotopic human bladder tumor growth by lentiviral gene transfer of endostatin.
Kikuchi E; Menendez S; Ohori M; Cordon-Cardo C; Kasahara N; Bochner BH
Clin Cancer Res; 2004 Mar; 10(5):1835-42. PubMed ID: 15014038
[TBL] [Abstract][Full Text] [Related]
13. Curcumin Suppresses microRNA-7641-Mediated Regulation of p16 Expression in Bladder Cancer.
Wang K; Tan SL; Lu Q; Xu R; Cao J; Wu SQ; Wang YH; Zhao XK; Zhong ZH
Am J Chin Med; 2018; 46(6):1357-1368. PubMed ID: 30149755
[TBL] [Abstract][Full Text] [Related]
14. Genetic evidence in melanoma and bladder cancers that p16 and p53 function in separate pathways of tumor suppression.
Gruis NA; Weaver-Feldhaus J; Liu Q; Frye C; Eeles R; Orlow I; Lacombe L; Ponce-Castaneda V; Lianes P; Latres E
Am J Pathol; 1995 May; 146(5):1199-206. PubMed ID: 7747814
[TBL] [Abstract][Full Text] [Related]
15. Lentiviral vector-mediated PAX6 overexpression promotes growth and inhibits apoptosis of human retinoblastoma cells.
Li L; Li B; Zhang H; Bai S; Wang Y; Zhao B; Jonas JB
Invest Ophthalmol Vis Sci; 2011 Oct; 52(11):8393-400. PubMed ID: 21948554
[TBL] [Abstract][Full Text] [Related]
16. Restoration of wild-type p16 down-regulates vascular endothelial growth factor expression and inhibits angiogenesis in human gliomas.
Harada H; Nakagawa K; Iwata S; Saito M; Kumon Y; Sakaki S; Sato K; Hamada K
Cancer Res; 1999 Aug; 59(15):3783-9. PubMed ID: 10446996
[TBL] [Abstract][Full Text] [Related]
17. Interaction between p53 and p16 expressed by adenoviral vectors in human malignant glioma cell lines.
Kim SK; Wang KC; Cho BK; Chung HT; Kim YY; Lim SY; Lee CT; Kim HJ
J Neurosurg; 2002 Jul; 97(1):143-50. PubMed ID: 12134905
[TBL] [Abstract][Full Text] [Related]
18. [Gene therapy study on bladder cancer with recombinant adenoviral vector carrying LRIG1 gene driven by Survivin promoter].
Yan ZJ; Cheng Y; Jiang JH; Hu JS; Shi XD
Zhonghua Wai Ke Za Zhi; 2012 Aug; 50(8):732-6. PubMed ID: 23157908
[TBL] [Abstract][Full Text] [Related]
19. Adenoviral p53 gene transfer in human bladder cancer cell lines: cytotoxicity and synergy with cisplatin.
Pagliaro LC; Keyhani A; Liu B; Perrotte P; Wilson D; Dinney CP
Urol Oncol; 2003; 21(6):456-62. PubMed ID: 14693272
[TBL] [Abstract][Full Text] [Related]
20. Gene therapy for bladder cancer.
Pagliaro LC
World J Urol; 2000 Apr; 18(2):148-51. PubMed ID: 10854151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
